Transient remission of nonalcoholic fatty liver disease decreases the risk of incident type 2 diabetes mellitus in Japanese men. Issue 12 (December 2016)

• Record Type: Journal Article
• Authors: Fukuda, Takuya; Hamaguchi, Masahide; Kojima, Takao; Mitsuhashi, Kazuteru; Hashimoto, Yoshitaka; Ohbora, Akihiro; Kato, Takahiro; Nakamura, Naoto; Fukui, Michiaki
• Is Part Of: European journal of gastroenterology & hepatology. Volume 28:Issue 12(2016:Dec.)
• Publication Date: 2016-12
• Subjects: cohort study -- diabetes -- epidemiology of diabetes -- fatty liver -- nonalcoholic fatty liver disease; Digestive organs -- Diseases -- Periodicals; Liver -- Diseases -- Periodicals; Digestive organs -- Diseases; Liver -- Diseases; Periodicals; 616.33
• DOI: 10.1097/MEG.0000000000000736
• Languages: English
• ISSNs: 0954-691X

Abstract

Abstract : Introduction: It is unclear how the transient remission of nonalcoholic fatty liver disease (NAFLD) affects incident type 2 diabetes mellitus (T2DM). Here, we sought to determine the effect of the transient remission of NAFLD on incident T2DM in Japanese men. Materials and methods: We used a population-based health check-up program. The primary outcome was set as incident T2DM. We divided the participants who showed NAFLD at the time of enrollment into three groups according to their clinical course of NAFLD: the Regression group, in which the participants showed a regression of NAFLD and no relapse during the follow-up period; the Transient Remission group, in which participants achieved a transient remission of NAFLD, but had a relapse of NAFLD; and the Persistent group, in which participants showed NAFLD throughout the follow-up. The Never group of participants who did not show NAFLD throughout the follow-up served as a reference. Results: The incidence rates of T2DM in the Never group, the Regression group, the Transient Remission group, and the Persistent group were 4.7% (62/1306), 9.2% (14/153), 18.0% (25/139), and 35.1% (120/342), respectively. In a multivariate Cox regression analysis with covariates, the adjusted hazard ratios for incident T2DM compared with the Never group were as follows: Regression group: 1.08 [95% confidence interval (CI) 0.53–2.04, P =0.81], Transient Remission group: 2.12 (95% CI 1.22–3.57, P <0.01), and Persistent group: 3.44 (95% CI 2.29–5.21, P <0.001). The adjusted hazard ratio of the Transient Remission group was significantly lower than that of the Persistent group ( P <0.05). Conclusion: Transient remission of NAFLD significantly decreased the risk of developing T2DM.